These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 7912819

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. EEG brain mapping and psychometry in age-associated memory impairment after acute and 2-week infusions with the hemoderivative Actovegin: double-blind, placebo-controlled trials.
    Saletu B, Grünberger J, Linzmayer L, Anderer P, Semlitsch HV.
    Neuropsychobiology; ; 24(3):135-48. PubMed ID: 2135068
    [Abstract] [Full Text] [Related]

  • 3. [Treatment of negative symptoms in schizophrenia by amisulpride. Review of the literature].
    Pélissolo A, Krebs MO, Olié JP.
    Encephale; 1996; 22(3):215-9. PubMed ID: 8767050
    [Abstract] [Full Text] [Related]

  • 4. Treatment of negative symptoms in schizophrenia with amisulpride.
    Boyer P, Lecrubier Y, Puech AJ, Dewailly J, Aubin F.
    Br J Psychiatry; 1995 Jan; 166(1):68-72. PubMed ID: 7894879
    [Abstract] [Full Text] [Related]

  • 5. EEG-brain mapping in schizophrenics with predominantly positive and negative symptoms. Comparative studies with remoxipride/haloperidol.
    Saletu B, Küfferle B, Anderer P, Grünberger J, Steinberger K.
    Eur Neuropsychopharmacol; 1990 Nov; 1(1):27-36. PubMed ID: 1983779
    [Abstract] [Full Text] [Related]

  • 6. Clinical update on amisulpride in deficit schizophrenia.
    Rein W, Turjanski S.
    Int Clin Psychopharmacol; 1997 May; 12 Suppl 2():S19-27. PubMed ID: 9218164
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Dose-related effects of amisulpride on five dimensions of psychopathology in patients with acute exacerbation of schizophrenia.
    Müller MJ, Wetzel H, Eich FX, Rein W, Puech A, Benkert O, Amisulpride Study Group.
    J Clin Psychopharmacol; 2002 Dec; 22(6):554-60. PubMed ID: 12454554
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Evaluation of efficacy and tolerance of amisulpride in treatment of schizophrenic psychoses].
    Chabannes JP, Pelissolo A, Farah S, Gerard D.
    Encephale; 1998 Dec; 24(4):386-92. PubMed ID: 9809244
    [Abstract] [Full Text] [Related]

  • 11. Ziprasidone and amisulpride effectively treat negative symptoms of schizophrenia: results of a 12-week, double-blind study.
    Olié JP, Spina E, Murray S, Yang R.
    Int Clin Psychopharmacol; 2006 May; 21(3):143-51. PubMed ID: 16528136
    [Abstract] [Full Text] [Related]

  • 12. Visualizing central effects of S-adenosyl-L-methionine (SAMe), a natural molecule with antidepressant properties, by pharmaco-EEG mapping.
    Saletu-Zyhlarz GM, Anderer P, Linzmayer L, Semlitsch HV, Assandri A, Prause W, Hassan Abu-Bakr M, Lindeck-Pozza E, Saletu B.
    Int J Neuropsychopharmacol; 2002 Sep; 5(3):199-215. PubMed ID: 12366873
    [Abstract] [Full Text] [Related]

  • 13. Acute central effects of the calcium channel blocker and antiglutamatergic drug caroverine. Double-blind, placebo-controlled, EEG mapping and psychometric studies after intravenous and oral administration.
    Saletu B, Grünberger J, Anderer P, Linzmayer L, König P.
    Arzneimittelforschung; 1995 Mar; 45(3):217-29. PubMed ID: 7741773
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Amisulpride compared with standard neuroleptics in acute exacerbations of schizophrenia: three efficacy studies.
    Freeman HL.
    Int Clin Psychopharmacol; 1997 May; 12 Suppl 2():S11-7. PubMed ID: 9218163
    [Abstract] [Full Text] [Related]

  • 16. Comparative placebo-controlled pharmacodynamic studies with zotepine and clozapine utilizing pharmaco-EEG and psychometry.
    Saletu B, Grünberger J, Linzmayer L, Anderer P.
    Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):12-27. PubMed ID: 2883677
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Negative symptoms and EEG alpha activity in schizophrenic patients.
    Merrin EL, Floyd TC.
    Schizophr Res; 1992 Oct; 8(1):11-20. PubMed ID: 1358182
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.